United States · Series E startup
6 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$144Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $10M sold, first sale Feb 2014
Index Ventures
Sofinnova Investments
New Leaf Venture Partners
Advent Venture Partners
Aisling CapitalReported by finsmes.comSEC filing: $10.0M sold, first sale Oct 2013
Reported by sec.govSEC filing: $12M sold, first sale Jul 2013
Reported by fiercebiotech.comSEC filing: $8.0M sold, first sale Jan 2013
Reported by versartis.comSEC filing: $14M sold, first sale Feb 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Index VenturesNew Leaf Venture PartnersAdvent Venture PartnersAisling CapitalSofinnova Investments
Advent Life Sciences LlpamunixMissing a round, or an investor who was in one? Tell us.
Versartis's investors include Index Ventures, New Leaf Venture Partners, Advent Venture Partners, Aisling Capital and Sofinnova Investments, and 2 more on record.
Versartis has raised $144M across 6 rounds since 2009.
Versartis's most recent round was a Series E of $55M in Feb 2014.
Its most recent round, $55M in Feb 2014, is also its largest on record.
Versartis's first round on record, in Jun 2009, was backed by Index Ventures.
Versartis's latest named round is a Series E, in Feb 2014.
Versartis is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·